| Jennifer Lynne Jarvie, MD | |
|
100 Cook St Ste 412, Denver, CO 80206-5340 | |
| (720) 516-9403 | |
| (720) 516-9431 |
| Full Name | Jennifer Lynne Jarvie |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 13 Years |
| Location | 100 Cook St Ste 412, Denver, Colorado |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790084945 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | DR.0055241 (Colorado) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hca-healthone Dba Swedish Medical Center | Englewood, CO | Hospital |
| Rose Medical Center | Denver, CO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Healthone Clinic Services - Cardiovascular Llc | 0244459998 | 28 |
News Archive
Using red blood cells modified to carry disease-specific antigens, scientists in the laboratories of Hidde Ploegh and Harvey Lodish have prevented and alleviated two autoimmune diseases—multiple sclerosis (MS) and type 1 diabetes—in early stage mouse models.
SAS, the leader in business analytics software and services, and GE Healthcare have entered into a joint development and marketing agreement by which GE Healthcare will leverage SAS technology to analyze and deliver relevant, detailed patient safety information to help hospitals address preventable adverse medical events.
Treating patients with locally advanced inoperable breast cancer is an extremely difficult task. The overwhelming majority of patients treated for this disease suffer relapse and, despite the best multimodal treatment, do not survive. There is a medical need to examine current and potential treatments, and EORTC researchers have recently published an article in Nature Reviews Clinical Oncology concerning this topic.
SCIEX announced today a research collaboration with Labor Berlin, the largest clinical laboratory in Germany, for the development of a hybrid Quadrupole Time-of-Flight (TOF) MS/MS reference library of relevant forensic chemical compounds
› Verified 4 days ago
| Entity Name | Healthone Clinic Services - Cardiovascular Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447584933 PECOS PAC ID: 0244459998 Enrollment ID: O20140911002174 |
News Archive
Using red blood cells modified to carry disease-specific antigens, scientists in the laboratories of Hidde Ploegh and Harvey Lodish have prevented and alleviated two autoimmune diseases—multiple sclerosis (MS) and type 1 diabetes—in early stage mouse models.
SAS, the leader in business analytics software and services, and GE Healthcare have entered into a joint development and marketing agreement by which GE Healthcare will leverage SAS technology to analyze and deliver relevant, detailed patient safety information to help hospitals address preventable adverse medical events.
Treating patients with locally advanced inoperable breast cancer is an extremely difficult task. The overwhelming majority of patients treated for this disease suffer relapse and, despite the best multimodal treatment, do not survive. There is a medical need to examine current and potential treatments, and EORTC researchers have recently published an article in Nature Reviews Clinical Oncology concerning this topic.
SCIEX announced today a research collaboration with Labor Berlin, the largest clinical laboratory in Germany, for the development of a hybrid Quadrupole Time-of-Flight (TOF) MS/MS reference library of relevant forensic chemical compounds
› Verified 4 days ago
| Entity Name | Knd Development 59 Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447747654 PECOS PAC ID: 3678602802 Enrollment ID: O20170128000179 |
News Archive
Using red blood cells modified to carry disease-specific antigens, scientists in the laboratories of Hidde Ploegh and Harvey Lodish have prevented and alleviated two autoimmune diseases—multiple sclerosis (MS) and type 1 diabetes—in early stage mouse models.
SAS, the leader in business analytics software and services, and GE Healthcare have entered into a joint development and marketing agreement by which GE Healthcare will leverage SAS technology to analyze and deliver relevant, detailed patient safety information to help hospitals address preventable adverse medical events.
Treating patients with locally advanced inoperable breast cancer is an extremely difficult task. The overwhelming majority of patients treated for this disease suffer relapse and, despite the best multimodal treatment, do not survive. There is a medical need to examine current and potential treatments, and EORTC researchers have recently published an article in Nature Reviews Clinical Oncology concerning this topic.
SCIEX announced today a research collaboration with Labor Berlin, the largest clinical laboratory in Germany, for the development of a hybrid Quadrupole Time-of-Flight (TOF) MS/MS reference library of relevant forensic chemical compounds
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jennifer Lynne Jarvie, MD 2695 Rocky Mountain Ave Ste 150, Loveland, CO 80538-9071 Ph: (970) 624-2412 | Jennifer Lynne Jarvie, MD 100 Cook St Ste 412, Denver, CO 80206-5340 Ph: (720) 516-9403 |
News Archive
Using red blood cells modified to carry disease-specific antigens, scientists in the laboratories of Hidde Ploegh and Harvey Lodish have prevented and alleviated two autoimmune diseases—multiple sclerosis (MS) and type 1 diabetes—in early stage mouse models.
SAS, the leader in business analytics software and services, and GE Healthcare have entered into a joint development and marketing agreement by which GE Healthcare will leverage SAS technology to analyze and deliver relevant, detailed patient safety information to help hospitals address preventable adverse medical events.
Treating patients with locally advanced inoperable breast cancer is an extremely difficult task. The overwhelming majority of patients treated for this disease suffer relapse and, despite the best multimodal treatment, do not survive. There is a medical need to examine current and potential treatments, and EORTC researchers have recently published an article in Nature Reviews Clinical Oncology concerning this topic.
SCIEX announced today a research collaboration with Labor Berlin, the largest clinical laboratory in Germany, for the development of a hybrid Quadrupole Time-of-Flight (TOF) MS/MS reference library of relevant forensic chemical compounds
› Verified 4 days ago
Katrina Wagoner-hursh, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 1835 Franklin St, Denver, CO 80218 Phone: 303-338-4545 | |
Emily Martin Jones, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 8111 E Lowry Blvd, Denver, CO 80230 Phone: 720-848-0000 | |
Dr. Jesus Heliodoro Hermosillo Rodriguez, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2045 N Franklin St, Denver, CO 80205 Phone: 303-338-4545 | |
Margaret Hay, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1601 E 19th Ave Ste 3100, Denver, CO 80218 Phone: 303-863-0300 Fax: 303-863-7014 | |
Dr. Alan W Burgess, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 1601 E 19th Ave Ste 6000, Denver, CO 80218 Phone: 303-861-7001 Fax: 303-861-8624 | |
Dr. Sahibzada Mohsin Shah, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 777 Bannock St, Denver, CO 80204 Phone: 303-436-6000 | |
Shyam M Parkhie, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 130 Rampart Way, 300b, Denver, CO 80230 Phone: 720-343-1562 Fax: 720-343-1563 |